Thiourea - A chemical specialty with added value in technical and pharmaceutical markets
We present our newest product flyer with fresh design and detailed content on product qualities and applications.
Convince yourself of the wide range of applications in established and new markets:
- Extractive metallurgy: Extraction of strategic metals (e.g. copper, gold) from ores
- Pharma: Production of important drugs for the treatment of neurological diseases, e.g. Parkinson's disease
- Renewable energies: Activation of electrodes in hydrogen production
Tailored to the needs of the market, we offer different qualities: technical, chemical and pharmaceutical.
Contact
Angela Binder
About Alzchem
Alzchem is a globally active specialty chemicals company that is one of the market leaders in most of its fields of activity. Alzchem benefits from the three very different global developments climate change, population growth and longer life expectancy in a unique way. Alzchem products can offer attractive solutions for achieving the resulting social goals in a multitude of different applications.
The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
Alzchem Group AG’s broad product range includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are the company's response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments.
The company employs around 1,680 people at four production sites in Germany and a plant in Sweden, as well as three sales companies in the USA, China and England. Alzchem generated Group sales of around EUR 542.2 million and EBITDA of around EUR 61.4 million in 2022.